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Until recently, there has been little resistance to the notion that the differen- 
tiation  of T  killer  cells,  i.e.  cells  of the  L3T4-,  Lyt-2  + phenotype,  is  heavily 
dependent on help provided by other T  cells (1-3). In certain situations, however, 
purified  unprimed  Lyt-2  ÷  cells give high  MLR  and  cell-mediated  lympholysis 
(CMLy when exposed to H-2 differences in vitro (4, 5). By employing the bml 
and  bml2  mutant  mouse strains,  i.e.  strains differing from the C57BL/6  (B6) 
(H-2  b) strain only at class I (H-2K) or class II (I-A) loci, respectively, it was found 
that B6 Lyt-2  ÷ cells responded selectively to allo-class I differences, whereas B6 
L3T4  + cells (cells of T  helper phenotype) responded only to class II differences 
(5). In the case of Lyt-2  + cells, MLR to class I (bm 1) differences were not reduced 
by adding  anti-L3T4  mAb  to  the  cultures,  or  by removing  T  cells  from  the 
stimulator population.  These findings,  which are consistent with recent studies 
of Singer et al. (6), suggest that primary responses of Lyt-2  ÷ ceils can take place 
in the absence of Lyt-2- T  cells, at least in vitro. This paper presents evidence 
that,  as  in  vitro,  purified  Lyt-2  +  cells  can  mediate  alloaggressive  functions  in 
vivo. 
Materials and Methods 
Mice.  C57BL/6Kh (B6), B6.C-H-2  b'"~ (bml), B6.C-H-2  b'i2 (bml2), B10.BR, BALB.K, 
BALB/c, B10.D2, CBA/Ca (CBA), and Fl hybrid mice were obtained from the breeding 
colony of the Research Institute of Scripps Clinic. 
Irradiation.  A  Gamma  Cell  1,000  irradiator (500  rad/min) and a  Gamma  Cell  40 
irradiator (90  rad/min) (both  a37Cs sources from Atomic Energy of Canada,  Ottawa, 
Canada) were used to irradiate cells and mice, respectively. 
Media.  As described previously (5), RPMI  1640 or HBSS supplemented with either 
5% FCS or ~,-globulin-depleted horse serum were used. For MLR, cells were cultured in 
vitro in RPMI  1640 with 10% FCS plus standard additives (5). 
Monoclonal  Antibodies.  Anti-L3T4 (GK1.5, ascites fluid), anti-Lyt-2 (3.168.8, ascites 
fluid), anti-Thy-l.2 (Jlj, ascites fluid), and anti-B (J1 ld, culture supernatant) mAb and 
guinea pig serum as a source of C' were used as described previously (5). 
Purification  of T  Cell Subsets.  As  described in  detail elsewhere (5),  purified T  cell 
subsets  were  obtained  by subjecting  pooled  lymph  node  (LN) cells  to  mAb plus  C', 
followed by positive panning on mAb-coated dishes.  To make Lyt-2  ÷ cells, LN cells were 
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treated with a mixture of anti-B (J1 ld) and anti-L3T4 mAb plus C', washed, and then 
allowed to adhere to anti-Lyt-2-coated dishes. After gently washing nonadherent cells 
from the dishes, the adherent cells were eluted by vigorous pipetting after incubation at 
4°C for 1 h. The eluted cells were >99%  Lyt-2  ÷ cells by FACS analysis,  and contained 
no detectable L3T4  + cells.  An analogous procedure was  used to prepare >99%  pure 
L3T4  + cells, i.e. pretreatment of LN ceils with J1 ld and anti-Lyt-2 mAb plus C', followed 
by positive panning on anti-L3T4-coated dishes. 
MLR.  Doses of 1-2  x  105 responder cells  were cultured in flat-bottom microtiter 
plates with 5 x  10  s irradiated (1,500 rad) spleen cells as stimulators in a volume of 200 
#[, and then pulsed with 1 #Ci [nH]TdR 18 h before harvest (5). 
T Cell Proliferation  In Vivo.  Using a technique described previously (7), T  cells were 
transferred to allogeneic or syngeneic mice exposed to heavy irradiation (950-I ,000 rad) 
4-6 h before. At various times thereafter, the mice were injected intravenously with 25 
uCi [3H]TdR and killed 45 rain later. The spleens were dissolved in Soluene 100 (Packard 
Instrument Co., Downers Grove, IL) overnight, and counted in a ~8-counter after addition 
of scintillation fluid. Background counts in spleens of irradiated mice given [SH]TdR but 
no lymphoid cells (subtracted from the data shown) were 25-30 x  l0 s cpm. 
Thoracic Duct Lymphoeytes (TDL).  Cells  emerging through  a  cannula  placed  in  the 
thoracic duct were collected as described elsewhere (8). 
Measurement  of Splenomegaly  in  Newborn  Mice.  A  modification of the  technique of 
Simonsen (9) was used. T cells were transferred intraperitoneally in varying doses into 1- 
2-d-old neonatal mice. The recipients were killed 9-10 d later to measure the weight of 
the spleen vs. body weight. Splenic indices were calculated with respect to spleen/body 
weight ratios in control mice, i.e. mice given 10  ~ unseparated syngeneic T cells (J 11 d plus 
C'-treated LN). The formula for calculating splenic indices was: (spleen-to-body weight 
ratio for each mouse of experimental group)/(mean spleen-to-body weight ratio of mice 
given syngeneic T  cells). 
Assay for Lethal GVHD.  Adult mice aged 10-15 wk were exposed to heavy irradiation 
(950 rad) 4-6 h before transfer of T  cells and anti-Thy-1 plus C'-treated marrow cells 
given intravenously. Mice were inspected three times per week until death. No antibiotics 
were given to the mice. 
Skin  Grafting.  Ear skin  grafts  were applied  to  the  flank region  by the  method of 
Bi}lingham (10). 
Typing of Cells.  Cells were typed for cell surface expression of Thy-1, L3T4, and Lyt- 
2 markers by FACS analysis or cytotoxicity as described previously (5). 
Results 
In all of the experiments presented below, >99% purified L3T4  + and Lyt-2  + 
cells  were  prepared  by a  combination  of killing  and  panning  (Materials  and 
Methods). 
MLR In Vitro.  In prior studies (5), the evidence on MLR mediated by L3T4  ÷ 
and Lyt-2  + cells rested largely on experiments with B6 and B10.A mice. Before 
studying  the  function  of T  cell  subsets  in  vivo,  it  was  therefore  considered 
important  to examine  whether  the  responsiveness of Lyt-2  + cells  in  MLR  ex- 
tended  to  other  responder  strains.  Table  I  compares  MLR  by  T  cell  subsets 
taken  from  five different strains;  stimulators  were  pretreated  with  anti-Thy-1 
mAb plus C'. 
L3T4  ÷ cells from all strains tested gave high MLR to full H-2 differences, with 
peak  responses  usually  occurring on day 6.  Strain  variation  in  peak  responses 
was  comparatively  minor.  The  responsiveness  of B6  L3T4  ÷  cells  to  class  II 
(bml2) but not class  I  (bml) differences (5 and Table I) suggests that anti-H2 
responses by L3T4  + cells are directed selectively to class lI differences. 
As found previously with B6 cells (5), MLR by the five populations of Lyt-2  + 1000  IN  VIVO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
TABLE  I 
Comparative MLR of L3T4 + and Lyt-2 + CeUs from Various Strains of Mice 
Exp. 
Stimulators  Number of  (anti-Thy-I +  Stimulus  Responders*  responders  C'-treated)* 
[SH]TdR incorpora- 
tion (cpm X 103)  a 
Day  Day  Day 
4  5  6 
1  B6 L3T4 +  105 
B6 Lyt-2 + 
B6  Self  1,0  1.6  2.2 
bml  K  b~"l  3.3  3.7  6.1 
bml2  I-A  bml~  25.4  32.6  98.2 
(B6 x  CBA)F~  H-2  k  41.6  56.0  145.0 
B6  Self  0.2  0.2  0.1 
bm 1  K  bml  99.7  92.8  2.4 
bml2  I-A  brat2  0.8  0.8  2.5 
(B6 X CBA)FI  H-2  k  84.6  53.2  1.7 
CBA L3T4 ÷  2 X 105  CBA  Self  2.5  2.0  4.7 
(B6 × CBA)F1  H-2  b  55.2  159.0  327.0 
CBA Lyt-2  +  CBA  Self  0.1  0.2  0.1 
(B6 x CBA)Fj  H-2  ~  11.2  17.6  10.1 
BI0.BR L3T4 +  2 X 105  CBA  Self  1.5  2.1  3.2 
(B6 × CBA)Ft  H-2  b  85.2  196.9  100.2 
B10.BR Lyt-2  +  CBA  Self  0.7  0.3  0.6 
(B6 × CBA)FI  H-2  b  42.3  29.0  3,9 
BALB]c L3T4 +  2 ×  l0  S  BALB/c  Self  5.5  11.1  21.6 
(BALB/c x  BALB.K)F~  H-2  k  49.7  120.3  170.6 
BALB/c Lyt-2  ÷  BALB/c  Self  0.4  0.2  0.2 
(BALB/c × BALB.K)F1  H-2  k  40.9  16.4  1.0 
BI0.D2 L3T4 ÷  2 x  105  BALB/c  Self  6.0  7.2  12.4 
(BALB/c × BALB.K)F~  H-2  k  59.0  163.1  37.6 
BI0.D2 Lyt-2  ÷  BALB/c  Self  0.4  0.4  0.2 
(BALB/c × BALB.K)F1  H-2  k  75.4  30.7  3.7 
* H-2 haplotype of responders: B6, H-2b; CBA and B10.BR, H-2k; BALB/c and B10.D2,  H-2  d. 
* 5 ×  105 viable cells. 
§ Mean of triplicate cultures. SD, omitted for simplicity, were generally within 10-20% of the mean. 
cells to  full  H-2  differences peaked  quite  early, usually on  day 4,  and  then  fell 
sharply to near-background  levels by day 6;  background  counts with syngeneic 
stimulators were uniformly negligible. Since B6 Lyt-2  + cells are unresponsive to 
mutant class II differences (5 and Table  I), it seems likely that anti-H-2 MLR by 
Lyt-2  + cells are directed selectively to class I  differences.  In contrast to  L3T4 ÷ 
cells, MLR  of Lyt-2  ÷ cells showed  considerable strain variation, with very high 
responses produced  by B6 cells and only low responses by CBA cells. At day 4, 
MLR  with  B6  cells were appreciably higher  with  Lyt-2  +  than  L3T4 + cells; the 
reverse applied with  CBA  cells, the  response  of L3T4 ÷ cells far exceeding the 
Lyt-2  ÷ response.  In the case of the other three strains tested, B10.BR,  BALB/c, 
and B 10.D2, MLR by L3T4 ÷ and Lyt-2  + cells on day 4 were roughly comparable. 
Because  of the  availability of the  bml  and  bml2  mutant  strains,  B6  T  cell 
subsets were used for most of the in vivo experiments described below. Emphasis 
was  also  placed  on  studying  CBA  Lyt-2  +  cells  in  vivo,  since  these  cells  gave SPRENT  ET  AL.  1001 
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FIGURE  l.  Incorporation of [SH]TdR in spleens of irradiated (B6 X bmI 2)Fi (a) and (B6 x 
bml)F1 (b) mice injected with 0.5 x  l0  s B6 L3T4  +, B6 Lyt-2  +, or unseparated syngeneic T 
ceils,  given intravenously. Groups of mice were injected with [SH]TdR and killed at daily 
intervals, 45 rain after [SH]TdR injection (see text for details).  The data show the mean levels 
of radioactivity (_.+SD) recovered  from  the  spleens of the  recipients (3  mice/group) after 
subtraction of background counts (Materials and Methods). 
relatively poor responses in vitro. The low MLR of CBA Lyt-2  + cells to full H-2 
differences in vitro is not blocked by anti-L3T4 mAb (our unpublished results). 
Proliferative Responses In Vivo,  T  cell proliferation in vivo can be quantitated 
by tranferring T  cells into heavily irradiated mice and then pulsing the mice with 
['~H]TdR shortly before removing the spleen (Materials and  Methods).  At 4  d 
postinjection, levels of radioactivity in the spleen are directly proportional to the 
number of T  cells injected, within the range of 105-106 cells (11); provided that 
the T  cells are prepared from tissues, such as LN, that lack stem cells, the cells 
proliferating in the spleen of the recipients are almost entirely donor-derived T 
cells. 
The kinetics of the response of B6 T  cell subsets in irradiated (950 rad) (B6 × 
bm 1)F~ and (B6 x  bm 12)F~ mice is shown in Fig. 1  ; background counts observed 
in irradiated  mice given no cells have been subtracted from the data (Materials 
and  Methods).  B6 L3T4 + ceils responded strongly in bml2  F~  mice, but gave 
little  if any response in  bml  Fj  mice,  relative to control bml  F~  T  cells.  The 
reverse applied to B6 Lyt-2  ÷ cells. These cells gave strong responses in bml  F~ 
mice but virtually no response in bm 12 F1 mice. Peak responses occurred slightly 
earlier for B6 L3T4  + cells (day 4) than for B6 Lyt-2  + cells (day 5). 
When B6 T  cell subsets were transferred to H-2 semiallogeneic irradiated (B6 
×  CBA)F~  mice, only quite low responses were obtained,  both for L3T4 + and 
Lyt-2  +  cells  (Table  II).  Hh  resistance  (12)  probably accounted  for  these  low 
responses,  since split-dose irradiation  of the  recipients,  a  procedure  known  to 
overcome Hh resistance,  led to appreciably higher  responses (Table II). In the 
case of H-2  k responder cells [which are not subject to Hh resistance in (b x  k)Fl 
mice], CBA and B10.BR L3T4 + cells both gave high responses in (B6 ×  CBA)F~ 
mice. Intermediate responses were observed with B 10.BR Lyt-2  + cells. CBA Lyt- 1002  IN  VIVO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
TABLE  II 
Proliferative Response of Parental Strain L3T4 + and Lyt-2 + Cells in Irradiated 
(B6 × CBA)F~ Mice 
Irradiated  Radiation dose 
Cells injected  recipients  (rad) 
[3H]TdR incorporation 
(cpm ×  10S)/spleen (SD) 
Day 4  Day 5 
(B6 × CBA)F~ T  (B6 x  CBA)F,  950  8.2 (0.7)  0.5 (0.6) 
(B6 × CBA)F~ T  (B6 ×  CBA)F~  550 +  950  3.2 (4.6)  3.7 (1.2) 
B6 L3T4 ÷  B6  950  10.2  (3.1)  -- 
B6 L3T4 ÷  (B6 × CBA)F~  950  108.8 (16.2)  185.7 (30.4) 
B6 L3T4+  (B6 x  CBA)Ft  550 +  950  240.7 (35.4)  266.3 (40.9) 
B6 Lyt-2  ÷  B6  950  0.2 (0.5)  -- 
B6 Lyt-2  +  (B6 x  CBA)F~  950  59.4 (1.9)  100.2 (20,3) 
B6 Lyt-2  +  (B6 × CBA)Fj  550 +  950  119.5 (22.2)  186.4 (32.1) 
CBA L3T4  +  CBA  950  13.8  (3.4)  -- 
CBA L3T4  ÷  (B6 × CBA)F~  950  527.9 (25.7)  256.9 (33.2) 
CBA Lyt-2  ÷  CBA  950  3.5 (2.7)  -- 
CBA Lyt-2  +  (B6 × CBA)F~  950  29.9 (7.3)  41.0 (10.1) 
B10.BR L3T4 ÷  CBA  950  22.3 (5.9)  -- 
B10.BR L3T4  +  (B6 × CBA)F~  950  735.4 (117.5)  633.6 (92.4) 
B10.BR Lyt-2  +  CBA  950  18.2  (12.3)  -- 
B10.BR Lyt-2  ÷  (B6 ×  CBA)F,  950  86.0 (15.6)  301.7 (12.2) 
0.5 ×  106 T  cells were transferred intravenously to mice irradiated 4 h before; mice given split-dose 
irradiation received the first dose of radiation 2  wk before cell transfer and the second dose 4  h 
before cell transfer. The recipients were killed 4 or 5 d posttransfer, 45 rain after receiving 25/zCi 
[SH]TdR intravenously. Radioactivity in the spleens of the recipients was measured as described in 
Materials and Methods. The data are shown as mean radioactivity counts (SD) from three mice per 
group. Background counts have been subtracted (Materials and Methods). 
2 + cells gave only very low responses. As for Fig. 1, peak responses were observed 
on day 5 for Lyt-2  + cells and on day 4 for L3T4 + cells. 
TDL Outputs.  T  cell proliferation  in the lymphoid tissues of irradiated  H-2- 
incompatible mice is followed by entry of large numbers of blast T  cells into the 
central  lymph (13).  With  transfer  of small numbers of T  cells (<5  ×  106), the 
number of blasts entering  the lymph is proportional  to the number of T  cells 
injected.  Counting  T  blasts in  thoracic  duct  lymph thus provides direct  infor- 
mation on the extent of donor T  cell proliferation in the recipients. 
The data in Table III show TDL outputs in irradiated (950 rad) bml  F~ and 
bml2 F~  mice given 3 ×  106 unseparated  B6 T  cells or B6 T  cell subsets. The 
recipients were cannulated at 4 d posttransfer, and TDL were collected over the 
first  24  h  of drainage;  cells  collected  over the  first  14-18  h  were  typed  for 
expression of Thy-1, L3T4, and Lyt-2 markers, usually by FACS analysis. 
Whereas normal mice produce 5-15 ×  107 T  cells over a 24-h drainage period 
(8),  TDL  outputs  in  irradiated  mice  are  extremely  low,  i.e.  <106  cells/24  h 
(groups 1 and 6). Most of the residual cells in the lymph are resting radioresistant 
Thy-1 +,L3T4 + cells, Lyt-2  + cells being slightly more radiosensitive than  L3T4 + 
cells (14); B cells, which are highly radiosensitive,  are quite rare.  With transfer SPRENT  ET  AL. 
TABLE  III 
TDL Outputs in Irradiated Mice Given L3T4 + vs. Lyt-2 + Cells 
1003 
Group 
TDL (X 106)  Percent cells positive 
Donor cells  Irradiated  Mice]group  collected  for:* 
(3 x  106)  (950 tad) hosts  (n)  over 24 h 
(SD)  Thy-1  L3T4  Lyt-2 
1  --  (B6 × bml)Ft  5  0.7 (0.3)  92.1  64.1  13.9 
2  (B6 x bml)Ft T  (B6 × bml)Ft  5  2.3 (0.3)  99  48  48 
3  B6 L3T4  +  (B6 × bml)Fi  5  1.4 (0.2)  97.8  91.9  3.6 
4  B6 Lyt-2 ÷  (B6 × bml)F~  4  22.6 (4.6)  99.1  1.3  98.6 
5  B6 T  (B6 × bml)F~  3  12.4 (2.9)  98.6  5.9  92.4 
6  --  (B6 x bml2)F~  5  0.7 (0.2)  93.5  62.1  16.1 
7  (B6 × bml2)Ft T  (B6 × bml2)F1  4  1,5 (0.4)  98  53  46 
8  B6 L3T4 +  (B6 × bml2)Ft  3  29.7 (3.4)  99.7  99.5  0.9 
9  B6 Lyt-2  ÷  (B6 × bml2)F~  5  1.7 (1.2)  96.6  20.5  75.3 
10  B6T  (B6Xbml2)F~  4  21.6 (3.1)  98.5  88.5  14.1 
11  (B6 × CBA)Fj T  (B6 x CBA)Fj  3  1.6 (0.3)  100  61  36 
12  CBA L3T4 +  (B6 X CBA)Ft  3  16.9 (2.8)  100  99  1 
13  CBA Lyt-2  +  (B6 × CBA)Ft  4  6.1 (0.6)  100  5  93 
14  B10.BR  Lyt-2  +  (B6 × CBA)F~  5  12.7 (2.6)  100  2  94 
Mice were injected intravenously with 3 x  106 viable cells, either purified T  cell subsets or whole 
T cells (J 11 d-treated LN); cells were injected within 4-6 b of exposing the recipients to irradiation. 
Mice were cannulated 4 d posttransfer, and TDL were collected over the following 24 h. In most 
cases, FACS analysis was used to quantitate expression of cell surface markers, using aliquots of 
TDL collected over 14-16 h; TDL in groups 2, 7, and 11-14 were typed by cytotoxicity. When 
typing cells for expression of L3T4 molecules by cytotoxicity in groups 11-14, RL172 mAb was 
used (15); unlike GK 1.5 mAb, RL 172 mAb is highly efficient at lysing L3T4* blast cells. Cytotoxic 
indices with antihost (anti-KbD  b) 20-8-4s mAb (16) were 99% for group 11 cells, 1% for group 12 
cells, 5% for group 13 cells, and 2% for group 14 cells. 
* Cells for typing were pooled in groups 1-3, 6, 7, 9, and 11. For the other groups, TDL from 2-3 
individual mice were tested; for these groups the mean of the results is shown. 
of syngeneic T  cells into irradiated mice, TDL  ouputs increased two- to threefold, 
the  lymph-borne  cells consisting of a  1:1  ratio of L3T4+/Lyt-2 ÷ cells (groups  2 
and  7);  very few  of these cells (<5%)  were blast cells. In the case of irradiated 
bml  F~  recipients of B6  Lyt-2  + cells, very large numbers  of T  cells (>2  x  107 
cells/mouse) entered  the lymph (group 4);  these cells were nearly all blast cells, 
and  99%  were  Lyt-2  +.  In  marked  contrast,  only very few  T  cells (mostly small 
lymphocytes) were collected from bml  Fl mice given B6  L3T4 ÷ cells (group 3). 
Diammetrically opposite findings were observed in bm 12 F~ mice. Here, injection 
of B6 L3T4 + cells generated very large numbers  of lymph-borne T  blasts (>99% 
L3T4 +) (group 8), whereas injection of B6  Lyt-2  ÷ cells generated  very few cells 
(group 9), most of which were small lymphocytes. Contamination  with radiores- 
istant L3T4 + host cells is presumed  to account for the 20%  of L3T4 + cells in the 
lymph of bm 12 F~ given B6 Lyt-2  ÷ ceils. With transfer of unseparated  B6 T  cells 
(containing an -  1 : 1 ratio of L3T4+/Lyt-2 ÷ cells) to irradiated bm 1 F1 and bm 12 
F1  mice (groups 5  and  10),  TDL  outputs were high in both situations, and most 
of the  cells were  blasts.  In  bml  F1  recipients,  the  vast  majority (92%)  of the 
lymph-borne  cells were  Lyt-2  ÷, only 6%  of the cells being L3T4 +.  The  reverse 
applied in bml2  F~ recipients, 89%  of the cells being L3T4 + and  14%  Lyt-2  ÷. 1004  IN  V1VO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
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FmURE 2.  Splenomegaly  induced in newborn bml (a), bml2 (b), and (B6 x CBA)F1 (c) mice 
injected intraperitoneally with varying numbers of B6 (a-c) or CBA (c) L3T4  ÷ or Lyt-2  ÷ cells. 
The mice were killed at 9 d posttransfer to measure splenic indices (Materials  and Methods); 
indices >1.5 (dotted line) are considered to be significant. Each point represents the mean 
(+SD) of the splenic indices calculated for 3-5 mice/group. 
Table III also shows TDL outputs in  irradiated (B6  ×  CBA)Fj  recipients of 
CBA  L3T4 ÷ and  Lyt-2  + cells and BI0.BR  Lyt-2  + cells.  With transfer of CBA 
L3T4 + cells, large numbers of cells (>90% blasts) entered the lymph (group 12). 
TDL outputs were lower with transfer of Lyt-2  + cells, cell yields being appreciably 
higher for B10.BR cells than CBA cells; in both situations, the vast majority of 
the lymph-borne cells (>90%) were blasts. Only very low cell yields were found 
in  recipients  of syngeneic T  cells,  very few of these cells  (<5%)  being blasts. 
Cytotoxicity testing with anti-host mAb confirmed that the vast majority of the 
lymph-borne cells in groups  12-14 were of donor origin (Table III footnote). 
Splenomegaly in Neonatal Mice.  The capacity of B6 L3T4  + and B6 Lyt-2  + cells 
to elicit splenomegaly in newborn (1-2-d-old)  bml  and bml2 mice is shown in 
Fig. 2, a and b; cells were injected intraperitoneally, and spleen and body weights 
were measured at 9 d posttransfer to calculate splenic indices. It can be seen that 
B6  Lyt-2  +  cells  produced  marked  splenomegaly in  bml  mice,  but  no  splenic 
enlargement in bml2  mice (Fig. 2a).  Conversely, B6  L3T4  ÷ cells caused sple- 
nomegaly only in bln 12 and not bm 1 mice (Fig. 2 b). In addition to splenomegaly, 
B6 L3T4 ÷ ~  bm 12 mice and B6 Lyt-2  ÷ ~  bm 1 mice both displayed macroscopic 
liver lesions characteristic of GVHD (data not shown).  The  incidence of these 
lesions was comparable in the two groups, i.e. 80% with the highest dose of cells 
injected (5 ×  106). 
Splenomegaly  in  neonatal  (B6  x  CBA)F1  mice  (which  do  not  display  Hh 
resistance) is shown in Fig. 2 c. In the case of B6 T  cell subsets, L3T4 + and Lyt- 
2 + cells both caused marked splenomegaly, the potency of these two groups of 
cells being roughly comparable.  CBA T  cell subsets also both caused significant 
splenomegaly, although splenic indices were appreciably higher with L3T4  + cells 
than with Lyt-2  + cells. 
Lethal  GVHD.  The capacity of B6  T  cell subsets  to cause lethal GHVD  in 
irradiated (950 rad) homozygous bml2 and bml  mice is shown in Fig. 3, a  and 
b; similar results were observed in Fl recipients (data not shown). T  cell subsets SPRENT  ET  AL.  1005 
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FICURE 3.  Mortality in irradiated (950 tad) bml2 (a), bml  (b), and (B6  x  CBA)FI (c) mice 
injected intravenously with varying numbers of B6 (a and b) or CBA (c) L3T4  + or Lyt-2  + cells 
plus 4 x  106 anti-Thy-I plus C'-treated syngeneic marrow cells; 7-8 mice/group. 
were  injected  intravenously  together  with  T  cell-depleted  marrow  cells,  the 
marrow  cells  being  syngeneic  with  the  T  cells;  no  deaths  occurred  in  mice 
reconstituted with marrow cells alone. Both T cell subsets caused 100% incidence 
of lethal GHVD, B6 L3T4 + cells killing only bml2 and not bml  mice, and B6 
Lyt-2  + cells killing bml  but not bml2  mice.  Lethal GHVD also occurred with 
transfer of CBA T  cell subsets to irradiated (B6 x  CBA)F~  mice (Fig. 3 c). L3T4 + 
cells were highly potent,  low doses of cells (0.6 X  106) causing  100%  mortality 
by 10 d  posttransfer;  in other experiments,  100% mortality was observed with 
doses as low as 0.1  x  106 cells (data not shown).  Lyt-2  + cells were appreciably 
less potent, and only the highest dose tested (3 X  106) caused severe mortality. 
Rejection of Skin Allografis.  To examine the capacity of B6 T  cell subsets to 
cause skin  allograft  rejection,  adult  thymectomized  B6  mice  were exposed to 
heavy irradiation  (1,000-1,100 rad) and reconstituted with anti-Thy-1  plus C'- 
treated  syngeneic  marrow  cells (4  x  106) given  intravenously.  Thereafter  the 
mice were injected  intravenously  with  8-10  x  106 L3T4 + or Lyt-2  + cells and 
then grafted  1-2 d later with ear skin taken from bml and bml2 mice; the two 
grafts were placed contiguously on the flank.  To limit participation  of radiore- 
sistant host cells in graft rejection, the mice received a large dose of anti-Thy-1 
mAb 2  wk before T  cell transfer (Table IV, footnote). Two experiments were 
performed; one (Exp. 2) was arbitrarily terminated at 31 d (the mice were then 
used for another experiment) and the other (Exp.  1) at 50 d; technical failures 
complicated graft rejection in the second experiment with L3T4  + cells and only 
the data for Lyt-2  + cells are shown for this experiment. 
As seen in Table IV, both T  cells subsets caused graft rejection. With transfer 
of L3T4 + cells, all  five of the bml2  grafts were rejected rapidly with a  mean 
survival time of 17 d; only one of five of the bin1  grafts was rejected within the 
observation time, and the rejection of this graft occurred quite late (38 d). With 
injection of Lyt-2  + cells, only bm 1 and not bm 12 grafts were rejected; eight of 1006  IN  VIVO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
TABLE  IV 
Rejection of bm l  and bm12 Skin AUografts by Thymectomized,  Irradiated Marrow-protected B6 
Mice Injected with B6 L3T4 ÷ or B6 Lyt-2 + Cells 
Graft rejection 
Cells in-  Number of  Mean sur- 
Exp.  jected  cells injected  Skin graft  Grafts re- 
jected/total  Day of rejection  viva[ time 
(d) 
1  L3T4 ÷  8 X  106  bml  1/5  38  >50 
bml2  5/5  11, 14, 16,  18, 25  17 
1  Lyt-2  +  8 ×  106  bml  3/3  16,  16, 18  17 
bml2  0/3  --  >50 
2  Lyt-2  +  107  bml  5/6  11,  14, 19, 23, 31  20  ~ 
bml2  0•4*  --  >31 
See text for details. In Exp.  1, mice were thymectomized 8 wk before irradiation (1,000 rad) and 
given T  cells and skin grafts 8 wk later. In Exp. 2, mice were thymectomized 1 wk before irradiation 
(1,100 rad) and given T  cells and skin grafts 6 wk later. A dose of 200 #1 of ascites fluid (titer >  3 
x  106) of the anti-Thy-1 hybridoma, T24, was given to each of the mice 2 wk before T  cell transfer; 
this mAb is highly effective at removing T  cells in vivo (17). 
* The other two grafts in this group were technical failures, i.e. the grafts failed to take initially. 
* Excluding the one surviving graft (which survived >31 d). 
nine of the bml grafts were rejected, with a mean survival time of 17 d for Exp. 
1, and 20 d for Exp. 2. 
Discussion 
Current  information  on  the  function  of purified  T  cell  subsets in  vivo has 
come largely  from  studies in  rats.  Other  workers (18,  19) investigated alloag- 
gressive phenomena mediated by purified W3/25 + and OX8  + cells, the homologs 
of L3T4  + and Lyt-2  + cells. In the case of popliteal LN enlargement, only W3/25  ÷ 
cells caused significant  responses.  Both subsets, however, caused lethal GHVD 
in irradiated rats, although W3/25 + cells were more potent than OX8  + cells. 
Since antibodies specific for mouse L3T4 molecules have only recently become 
available,  most of the  information  on the  function  of mouse T  cell subsets in 
vivo is indirect and is based largely on comparing the response of unseparated T 
cells reacting to class II vs. class I differences. There is general agreement that 
class II differences elicit strong alloreactivity in vivo by all parameters examined, 
including T  cell proliferation and lethal GHVD in irradiated mice, splenomegaly 
induction  in newborn  mice, and  skin graft rejection (20-26).  Although  class I 
differences generally cause rapid rejection of allografts, other forms of alloaggres- 
sion  to  class  I  differences are  quite  variable,  the  intensity  of these  responses 
depending  on  the  assay  used  and  the  particular  class  I  differences  involved. 
Allelic class  I  differences are reported  to elicit minimal  T  cell proliferation  in 
vivo (24), and cause only very mild GHVD in sublethally irradiated  (400  rad) 
mice (23), although severe mortality can occur with heavily irradiated recipients 
(26); induction  of splenomegaly in neonates varies from very low to moderate, 
depending  on  the  allele  concerned  (25).  In  contrast  to  the  generally  weak 
alloreactivity to allelic class I differences, mutant class I differences elicit quite SPRENT  ET  AL.  1007 
strong responses as measured by induction  of splenomegaly and  lethal  GVHD 
(22, 26). Why antimutant  responses are so strong is unclear (22). 
Although the strain combinations tested in this paper were quite limited,  the 
results indicate that  highly purified  populations of L3T4  ÷ and  Lyt-2  + cells are 
each capable of responding to H-2 differences in vivo. The studies with bm 1 and 
bml2 mutant strains suggest that, as in vitro (5), B6 Lyt-2  + cells and L3T4  ÷ cells 
respond selectively to class I and class II differences, respectively. This selectivity 
applied  to  T  cell  DNA  synthesis and  blast  cell  generation  in  irradiated  mice, 
induction  of splenomegaly in  newborn  mice,  lethal  GVHD in  irradiated  mice, 
and skin allograft rejection. These data provide strong support for the view (27) 
that  recognition  of class I  and  class II  molecules correlates closely with T  cell 
expression of Lyt-2 and L3T4 molecules, respectively, at least for allorecognition. 
In the case of lethal  GHVD, we reported previously (26) that  semipurified  B6 
Lyt-2  + cells elicited severe mortality in irradiated bm 1 mice but also caused some 
mortality in  bml2  mice.  Tile fact that  the highly purified  Lyt-2  + cells used in 
the  present  experiments  failed  to  kill  bml2  mice  suggests  that  our  previous 
results reflected minor contamination of the Lyt-2  + population with L3T4 + cells. 
With regard to skin graft rejection, the selective rejection of bml  grafts by B6 
Lyt-2  + cells and bln 12 grafts by B6 L3T4 + cells suggests that the issue of whether 
graft  rejection  reflects Lyt-2+-mediated CTL activity or L3T4+-controlled  de- 
layed-type  hypersensitivity  (reviewed  in  28)  depends  largely  on  the  type  of 
alloantigen  difference  (class  I  vs.  class  II)  involved.  The  secondary  issue  of 
whether Lyt-2÷-mediated graft rejection and other functions of Lyt-2  + ceils are 
helper-independent  is discussed below. 
Although each of the three populations of Lyt-2  ÷ cells tested gave significant 
responses  in  vivo,  responses  were much  higher  with  B6  cells than  CBA  cells; 
B 10.BR cells gave intermediate responses. By all parameters tested, the response 
of B6 Lyt-2  + cells to bm 1 was as strong as the anti-class II response of B6 L3T4 ÷ 
cells reacting to bm 12; B6 Lyt-2  + cells also responded well to a full H-2 difference. 
The intensity of the in vivo responses of B6 Lyt-2  + cells correlated closely with 
the  very high  MLR displayed by these cells in  vitro.  Cell-for-cell, purified  B6 
Lyt-2  +  cells  were  more  potent  than  unseparated  T  cells,  as  manifested  by 
splenomegaly induction  (data not shown) and  blast cell generation  (Table III). 
The  high  responses  given  by B6  Lyt-2  + cells  contrasted  with  the  rather  low 
responses given by CBA Lyt-2  + cells (reacting against a whole H-2 [K, D, and L] 
difference).  As in  vitro,  CBA Lyt-2  + cells gave poor proliferative responses in 
vivo. These cells nevertheless evoked appreciable GVH reactions, and doses of 
3 ×  106 cells caused 100% mortality in heavily irradiated (B6 x  CBA)F~  mice. 
The  reason  for the marked  strain  variability in  the response of Lyt-2  + cells, 
both in vitro and in vivo, is unclear. In rats, one group reports (29) that purified 
OX8 + cells give very high  MLR in vitro,  whereas another  group (30),  using a 
different strain  combination,  asserts that  OX8  + cells give no response without 
added help. Although it is difficult to account for this striking difference in rats, 
we have recently found that  Lyt-2  + cells derived from a  series of H-2  b strains 
vary considerably in their capacity to give MLR to bin 1 (unpublished data). For 
example,  BALB.B ceils give much  lower responses than  B6 cells. This finding 1008  IN  VIVO  RESPONSES  OF  PURIFIED  T  CELL  SUBSETS 
suggests that background genes somehow influence the responsiveness of Lyt-2  ÷ 
cells. The identity of these genes is quite unknown. 
In the face of the considerable strain variation in the reactivity of purified Lyt- 
2 + cells, it is difficult to reach firm conclusions on the important issue of whether 
the  response  of  Lyt-2  +  cells  to  antigen  in  vivo  is  autonomous  or  requires 
exogenous help  from  L3T4 + cells.  For  in  vitro  responses,  we could find  no 
evidenc.e that contamination with L3T4 + ceils accounted for the B6 Lyt-2  + anti- 
bml  response,  either for  MLR  or  for early (day  4)  generation of CML  (5). 
Although the method used for preparing Lyt-2  + cells virtually eliminates L3T4 + 
cells from the responder population, the possibility that in vivo responses of Lyt- 
2 + cells reflect help from host-derived L3T4 + cells is less clear. It was mentioned 
earlier (see Results) that -  1% of the T  cell pool is resistant to heavy irradiation 
(e.g. 950 rad), and that most of these cells are L3T4 ÷ ceils. Although these few 
radioresistant cells are obvious candidates for providing help in vivo, these cells 
are  incapable  of responding  in  MLR  (at  least  within  5  d  of irradiating  the 
recipients),  probably because the cells have sustained  radiation-induced chro- 
mosomal damage (31). The possibility that these radioresistant cells might pro- 
duce a  minimal amount of help required by Lyt-2  + cells, however, cannot be 
discounted. Nevertheless, in view of the conspicuous lack of evidence that L3T4 + 
cells are required for Lyt-2  + responses in vitro, it seems highly likely that Lyt-2  + 
cells behave  similarly in  vivo,  especially for  short-term  assays such  as  T  cell 
proliferation in irradiated mice. 
Whether exogenous help is needed for more protracted in vivo responses of 
Lyt-2  + cells is less clear. In the case of B6 Lyt-2+-mediated skin graft rejection, 
it seems unlikely that host-derived L3T4 ÷ cells played a significant role because 
the (thymectomized) recipients were pretreated with  heavy irradiation  (1,100 
rad in one experiment), and received a large dose of opsonizing anti-Thy- 1 mAb 
before cell transfer; moreover, the recipients of Lyt-2  + cells did not reject bm 12 
grafts. It seems quite likely therefore that rejection of bml grafts by B6 Lyt-2  + 
cells does not depend on exogenous help. Bearing in mind that the B6 anti-bm 1 
response  is  so  intense,  however,  it  is  quite  possible  that  skin  graft  rejection 
directed to  other (weaker) class  I  differences will  prove to be heavily helper- 
dependent. Further studies on graft rejection by Lyt-2  + cells are clearly needed. 
The  question  of whether T-T  interaction  is  required  for  GVH  reactions 
deserves careful consideration. In the case of splenomegaly induction in neonates, 
bystander help from newly-formed host T  cells is difficult to exclude. We hope 
to address this question in the future by thymectomizing the recipients and/or 
giving the mice repeated doses of anti-L3T4 mAb. As for skin aliograft rejection 
(see  above),  it  might  seem  unlikely  that  host-derived  help  could  contribute 
significantly to lethal GVHD mediated by Lyt-2  + cells in heavily irradiated mice. 
Surprisingly,  however, very recent studies (unpublished) have suggested that 
exogenous help  is  indeed  important  for  Lyt-2÷-mediated GVHD.  Although 
quite low doses of B6 Lyt-2  + cells cause 100% mortality in irradiated bml mice, 
most of the deaths occur quite late, i.e. after day 30, even when large numbers 
of cells are injected. Supplementing the Lyt-2  ÷ cells with small doses of L3T4  + 
cells, however, leads to acute GVHD, with most deaths occurring before day 21 
(our unpublished data). This finding suggests that the late mortality caused by SPRENT  ET  AL.  1009 
Lyt-2  + cells  transferred alone  might depend  on  bystander help produced by 
newly-generated, donor-derived L3T4  + cells emerging from the host thymus. 
To  test  this  idea,  we  are  currently examining  whether  thymectomy of the 
irradiated recipients prevents Lyt-2  + cells  from causing mortality. If this were 
the case, the possibility would arise that although Lyt°2  + cells are able to function 
autonomously during the first 1-2 wk posttransfer, these cells eventually differ- 
entiate to a helper-dependent state; the cells revert to a resting phase, but then 
become reactivated when bystander help becomes available. In vitro studies of 
von Boehmer et al. (4) provide a precedent for this notion. 
Although Lyt-2  + and L3T4  + cells both responded in each of the in vivo assays 
tested, the effector functions of these cells are known to be quite different, at 
least in vitro. Hence, GVHD elicited by Lyt-2  + vs. L3T4  ÷ cells probably involves 
different cellular mechanisms. Indeed, we have observed distinct differences in 
the histopathology of mice with GVHD mediated by Lyt-2  ÷ vs. L3T4  + cells (to 
be published). Likewise, other workers (32, 33) have reported separate forms of 
GVHD in mice injected with class I- vs. class II-disparate cells.  As for GVHD, 
it also seems likely that Lyt-2  + and L3T4  + cells use different mechanisms to elicit 
graft rejection. Direct evidence on this question is clearly needed. 
Summary 
Highly purified populations of C57BL/6 (B6) L3T4  + and Lyt-2  + T cell subsets 
were compared for their capacity to exert alloreactivity to class I vs. class II H-2 
differences in vivo. B6  Lyt-2  + cells responded strongly to the class  I-different 
mutant, bml, as  manifested by (a)  DNA  synthesis in the spleen of irradiated 
mice followed by entry of blast cells into thoracic duct lymph, (b) induction of 
splenomegaly in  newborn  mice,  (c)  production of lethal  GVHD  in  irradiated 
mice, and (d) skin allograft rejection. By all of these parameters, B6 Lyt-2  + cells 
showed almost total unresponsiveness to the class  II-different mutant, bml2. 
Reciprocal results were observed with B6  L3T4  + cells,  these cells responding 
strongly against bm 12 but not against bm 1. In the case of purified T  cell subsets 
from other strains, CBA/Ca and B10.BR L3T4  ÷ cells both responded well to a 
full H-2 difference. Responses by Lyt-2  + cells  from these strains were weaker, 
especially for CBA/Ca cells.  The implications of these findings are discussed. 
Received  for publication 23 December 1985. 
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